Market Cap

Asia Vets Holdings Ltd Market Capitalization:

S$4.1 Million

SGD as of Jan. 1, 2024

US$3.1 Million

business Asia Vets Holdings Ltd Company Profile

Asia Vets Holdings Ltd Main Stock Listing

SGX: 5RE

Market Capitalization History of Asia Vets Holdings Ltd

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Medical Care Facilities
Company Market Cap (USD)
HCA Healthcare, Inc. $73.10 B
Dr. Sulaiman Al Habib Medical Services Group Company $26.92 B
Aier Eye Hospital Group Co. Ltd $19.49 B
Fresenius SE & Co KGaA $18.07 B
JD Health International, Inc. $15.61 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $586.39 B
UnitedHealth Group $504.47 B
Novo Nordisk $461.52 B
Johnson & Johnson $387.50 B
Merck $296.51 B

Yearly evolution of Asia Vets Holdings Ltd market cap

Date Market Cap YoY Change
Jan. 1, 2024 S$4.1 M -33.33%
Jan. 1, 2023 S$6.1 M -37.31%
Jan. 1, 2022 S$9.8 M -10.67%
Jan. 1, 2021 S$11.0 M -25.00%
Jan. 1, 2020 S$14.6 M -51.22%
Jan. 1, 2019 S$30.0 M -18.00%
Jan. 1, 2018 S$36.5 M 61.29%
Jan. 1, 2017 S$22.7 M -40.38%
Jan. 1, 2016 S$38.0 M 44.44%
Jan. 1, 2015 S$26.3 M 125.00%
Jan. 1, 2014 S$11.7 M -30.43%
Jan. 1, 2013 S$16.8 M 0.00%
Jan. 1, 2012 S$16.8 M -28.12%
Jan. 1, 2011 S$23.4 M

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +284.14%

$10,000 in April 2023 would now be $38,414 by following this algorithm daily at market close.

Boost your stocks returns with Disfold AI... Now!

Try Disfold AI for FREE

Asia Vets Holdings Ltd Categories

Singapore languages Healthcare languages Medical Care Facilities
Singapore Healthcare Singapore Medical Care Facilities

Stocks & Indices

Asia Vets Holdings Ltd has the following listings and related stock indices.


Stock: SGX: 5RE

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.